Jane Chung

Entity
Individual
Business address
C/O Sutro Biopharma, Inc., 310 Utah Ave., Suite 150, 94080 South San Francisco, CA
Insider ownership signature
/s/ David Pauling as attorney-in-fact for Jane Chung
All SEC filings
View on sec.gov
Get insider transactions for this reporting owner
Jane Chung has filed 21 SEC EDGAR filings since 8/11/2021

Latest Filings

Form type Document Filing Description Filing date Reporting date File number(s)
4 Open Document Open Filing Oct 16, 2025 Oct 15, 2025 001-38662
4 Open Document Open Filing Aug 26, 2025 Aug 9, 2025 001-38662
4 Open Document Open Filing Apr 8, 2025 Apr 4, 2025 001-38662
4 Open Document Open Filing Mar 6, 2025 Mar 4, 2025 001-38662
4 Open Document Open Filing Mar 4, 2025 Mar 1, 2025 001-38662
4 Open Document Open Filing Dec 3, 2024 Dec 1, 2024 001-38662
4 Open Document Open Filing Aug 13, 2024 Aug 9, 2024 001-38662
4 Open Document Open Filing 4 Jun 24, 2024 Jun 20, 2024 000-51531
4 Open Document Open Filing Mar 7, 2024 Mar 5, 2024 001-38662
4 Open Document Open Filing Mar 6, 2024 Mar 4, 2024 001-38662
4 Open Document Open Filing Mar 5, 2024 Mar 1, 2024 001-38662
4 Open Document Open Filing FORM 4 SUBMISSION Dec 4, 2023 Dec 1, 2023 001-38662
4 Open Document Open Filing FORM 4 SUBMISSION Aug 11, 2023 Aug 9, 2023 001-38662
4 Open Document Open Filing FORM 4 SUBMISSION Jun 9, 2023 Jun 8, 2023 000-51531
4 Open Document Open Filing FORM 4 SUBMISSION Mar 7, 2023 Mar 3, 2023 001-38662
4 Open Document Open Filing FORM 4 SUBMISSION Aug 11, 2022 Aug 10, 2022 000-51531
3 Open Document Open Filing FORM 3 SUBMISSION Aug 11, 2022 Aug 10, 2022 000-51531
4 Open Document Open Filing FORM 4 SUBMISSION Aug 10, 2022 Aug 9, 2022 001-38662
4 Open Document Open Filing FORM 4 SUBMISSION Mar 7, 2022 Mar 4, 2022 001-38662
4 Open Document Open Filing FORM 4 SUBMISSION Aug 11, 2021 Aug 9, 2021 001-38662
3 Open Document Open Filing FORM 3 SUBMISSION Aug 11, 2021 Aug 9, 2021 001-38662